FDA clearance for Binax Bacterial Meningitis
go back to news archivesBinax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information
Posted on December 15, 2001
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
-
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
-
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
-
IBQC 2025
-
IFU Technical Workshop 2025
-
Validation of Water Systems for Microbial Control
-
USP Chapter <86> and the Move to Recombinant Methods
-
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
-
British Society For Microbial Technology 40th Anniversary Microbiology Conference
-
Sampling and Microbial Testing of Water and Data Trending
